Form 4: Corbus Pharmaceuticals Chief Medical Officer Sells Shares to Cover Tax Obligations

Dominic Smethurst, Chief Medical Officer of Corbus Pharmaceuticals, sold shares to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• On March 6, 2025, Dominic Smethurst, the Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc., sold 6,393 shares of common stock at a weighted average price of $6.7777.
• The sale was mandated by the issuer to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
• Following the transaction, Smethurst beneficially owns 70,807 shares, which includes 64,700 unvested RSUs.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes). It doesn't indicate positive or negative sentiment about the company's prospects.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes upon vesting of stock awards.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.

Key Dates

Keywords

Form 4, Corbus Pharmaceuticals, CRBP, Dominic Smethurst, Chief Medical Officer, Stock Sale, Restricted Stock Units, Tax Withholding